{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T13:26:31Z","timestamp":1770297991005,"version":"3.49.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.bpg.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T22:00:15Z","timestamp":1399068015000},"page":"399-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exploring &amp; exploiting our \u2018other self\u2019 \u2013 Does the microbiota hold the key to the future therapy in Crohn's?"],"prefix":"10.1016","volume":"28","author":[{"given":"Lea-Maxie","family":"Haag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7415","key":"10.1016\/j.bpg.2014.04.001_bib1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"issue":"5728","key":"10.1016\/j.bpg.2014.04.001_bib2","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3748\/wjg.v17.i5.557","article-title":"Intestinal microbiota in inflammatory bowel disease: friend of foe?","volume":"17","author":"Fava","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"7351","key":"10.1016\/j.bpg.2014.04.001_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10208","article-title":"Intestinal homeostasis and its breakdown in inflammatory bowel disease","volume":"474","author":"Maloy","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2014.04.001_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.immunol.021908.132657","article-title":"Regulatory lymphocytes and intestinal inflammation","volume":"27","author":"Izcue","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"34","key":"10.1016\/j.bpg.2014.04.001_bib6","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1086\/510385","article-title":"The role of microbes in Crohn's disease","volume":"44","author":"Eckburg","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bpg.2014.04.001_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/089106001750462669","article-title":"The host genotype affects the bacterial community in the human gastrointestinal tract","volume":"13","author":"Zoetendal","year":"2001","journal-title":"Microb Ecol Health Dis"},{"issue":"5778","key":"10.1016\/j.bpg.2014.04.001_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Science"},{"issue":"5717","key":"10.1016\/j.bpg.2014.04.001_bib10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"Backhed","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bpg.2014.04.001_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ibd.21108","article-title":"Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency","volume":"16","author":"Thibault","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib12","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/0016-5085(95)90756-4","article-title":"Effect of germfree state on the capacities of isolated rat colonocytes to metabolize n-butyrate, glucose, and glutamine","volume":"109","author":"Cherbuy","year":"1995","journal-title":"Gastroenterology"},{"issue":"6145","key":"10.1016\/j.bpg.2014.04.001_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.bpg.2014.04.001_bib14","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.bpg.2014.04.001_bib15","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1136\/gut.2010.216259","article-title":"Nod2 is essential for temporal development of intestinal microbial communities","volume":"60","author":"Rehman","year":"2011","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib16","first-page":"700","article-title":"NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer","volume":"123","author":"Couturier-Maillard","year":"2013","journal-title":"J\u00a0Clin Invest"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"6080","key":"10.1016\/j.bpg.2014.04.001_bib18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1126\/science.1219328","article-title":"Microbial exposure during early life has persistent effects on natural killer T cell function","volume":"336","author":"Olszak","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bpg.2014.04.001_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.smim.2007.10.009","article-title":"Th17 cells and mucosal host defense","volume":"19","author":"Aujla","year":"2007","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib21","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.coi.2007.07.020","article-title":"Th17: the third member of the effector T cell trilogy","volume":"19","author":"Bettelli","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"6015","key":"10.1016\/j.bpg.2014.04.001_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1126\/science.1198469","article-title":"Induction of colonic regulatory T cells by indigenous Clostridium species","volume":"331","author":"Atarashi","year":"2011","journal-title":"Science"},{"issue":"7461","key":"10.1016\/j.bpg.2014.04.001_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nature12331","article-title":"Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota","volume":"500","author":"Atarashi","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0092-8674(93)80067-O","article-title":"Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene","volume":"75","author":"Sadlack","year":"1993","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"issue":"6401","key":"10.1016\/j.bpg.2014.04.001_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/360225a0","article-title":"Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages","volume":"360","author":"Mombaerts","year":"1992","journal-title":"Nature"},{"issue":"8770","key":"10.1016\/j.bpg.2014.04.001_bib27","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0140-6736(91)90663-A","article-title":"Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum","volume":"338","author":"Rutgeerts","year":"1991","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bpg.2014.04.001_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","article-title":"An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system","volume":"122","author":"Mazmanian","year":"2005","journal-title":"Cell"},{"issue":"43","key":"10.1016\/j.bpg.2014.04.001_bib29","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.bpg.2014.04.001_bib30","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/ibd.20903","article-title":"Low counts of Faecalibacterium prausnitzii in colitis microbiota","volume":"15","author":"Sokol","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib31","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/ismej.2007.52","article-title":"Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum","volume":"1","author":"Baumgart","year":"2007","journal-title":"ISME J"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1053\/j.gastro.2011.01.054","article-title":"The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases","volume":"140","author":"Chassaing","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib33","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2010.223263","article-title":"Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives","volume":"60","author":"Joossens","year":"2011","journal-title":"Gut"},{"issue":"7475","key":"10.1016\/j.bpg.2014.04.001_bib34","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nature12599","article-title":"Paneth cells as a site of origin for intestinal inflammation","volume":"503","author":"Adolph","year":"2013","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib35","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/j.gastro.2011.02.048","article-title":"Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease","volume":"140","author":"Kaser","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bpg.2014.04.001_bib36","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s10620-007-0171-0","article-title":"A\u00a0meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease","volume":"53","author":"Rahimi","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.bpg.2014.04.001_bib37","first-page":"690S","article-title":"Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome","volume":"140","author":"Haller","year":"2010","journal-title":"J\u00a0Nutr"},{"issue":"11","key":"10.1016\/j.bpg.2014.04.001_bib38","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1136\/gut.2003.037325","article-title":"Modulation of human dendritic cell phenotype and function by probiotic bacteria","volume":"53","author":"Hart","year":"2004","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2014.04.001_bib39","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CDLI.8.4.695-701.2001","article-title":"Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10","volume":"8","author":"von der Weid","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.bpg.2014.04.001_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.2001.27224","article-title":"Probiotic bacteria enhance murine and human intestinal epithelial barrier function","volume":"121","author":"Madsen","year":"2001","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib41","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/j.gastro.2004.02.003","article-title":"DNA from probiotic bacteria modulates murine and human epithelial and immune function","volume":"126","author":"Jijon","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib42","doi-asserted-by":"crossref","first-page":"e4365","DOI":"10.1371\/journal.pone.0004365","article-title":"Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation","volume":"4","author":"Hoermannsperger","year":"2009","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.MIB.0000158158.55955.de","article-title":"Nonpathogenic Escherichia coli strain Nissle1917 prevents murine acute and chronic colitis","volume":"11","author":"Kamada","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib44","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0016-5085(99)70013-2","article-title":"Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice","volume":"116","author":"Madsen","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00054725-200203000-00001","article-title":"Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice","volume":"8","author":"Schultz","year":"2002","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib46","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.4049\/jimmunol.174.6.3237","article-title":"Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells","volume":"174","author":"Di Giacinto","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.bpg.2014.04.001_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1017\/S0007114507257770","article-title":"A\u00a0comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis","volume":"97","author":"Peran","year":"2007","journal-title":"Br J Nutr"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib48","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3748\/wjg.v13.i2.236","article-title":"Correlation between in\u00a0vitro and in\u00a0vivo immunomodulatory properties of lactic acid bacteria","volume":"13","author":"Foligne","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.bpg.2014.04.001_bib49","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1128\/IAI.01449-05","article-title":"Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways","volume":"74","author":"Grabig","year":"2006","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.bpg.2014.04.001_bib50","doi-asserted-by":"crossref","first-page":"e1308","DOI":"10.1371\/journal.pone.0001308","article-title":"Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity","volume":"2","author":"Ukena","year":"2007","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.bpg.2014.04.001_bib51","doi-asserted-by":"crossref","first-page":"e1000112","DOI":"10.1371\/journal.ppat.1000112","article-title":"Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation","volume":"4","author":"O'Mahony","year":"2008","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/11632710-000000000-00000","article-title":"Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients","volume":"72","author":"Jonkers","year":"2012","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib53","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.bpg.2014.04.001_bib54","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"issue":"9179","key":"10.1016\/j.bpg.2014.04.001_bib55","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bpg.2014.04.001_bib56","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","article-title":"Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management","volume":"6","author":"Dignass","year":"2012","journal-title":"J\u00a0Crohn's Colitis"},{"issue":"3","key":"10.1016\/j.bpg.2014.04.001_bib57","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S0029665107005563","article-title":"Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials","volume":"66","author":"Hedin","year":"2007","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"10.1016\/j.bpg.2014.04.001_bib58","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00005176-200010000-00024","article-title":"Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study","volume":"31","author":"Gupta","year":"2000","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.bpg.2014.04.001_bib59","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1023\/A:1005588911207","article-title":"Saccharomyces boulardii in maintenance treatment of Crohn's disease","volume":"45","author":"Guslandi","year":"2000","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2014.04.001_bib60","doi-asserted-by":"crossref","first-page":"G4179","DOI":"10.1016\/S0016-5085(00)85267-1","article-title":"Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study vs mesalamine","volume":"118","author":"Campieri","year":"2000","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2014.04.001_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gut.51.3.405","article-title":"Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG","volume":"51","author":"Prantera","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2014.04.001_bib62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-230X-4-5","article-title":"Lactobacillus GG in inducing and maintaining remission of Crohn's disease","volume":"4","author":"Schultz","year":"2004","journal-title":"BMC gastroenterol"},{"issue":"9","key":"10.1016\/j.bpg.2014.04.001_bib63","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/01.MIB.0000175905.00212.2c","article-title":"A\u00a0randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease","volume":"11","author":"Bousvaros","year":"2005","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib64","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/gut.2005.076604","article-title":"Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial","volume":"55","author":"Marteau","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ibd.20063","article-title":"Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection","volume":"13","author":"Van Gossum","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.bpg.2014.04.001_bib66","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00004836-199712000-00021","article-title":"Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease?","volume":"25","author":"Malchow","year":"1997","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.bpg.2014.04.001_bib67","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cgh.2013.02.021","article-title":"Saccharomyces boulardii does not prevent relapse of Crohn's disease","volume":"11","author":"Bourreille","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2014.04.001_bib68","first-page":"122","article-title":"Role of the enteric microbiota in intestinal homeostasis and inflammation","volume":"68C","author":"Koboziev","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib69","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1572-0241.2001.03802.x","article-title":"Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat","volume":"96","author":"Videla","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2014.04.001_bib70","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10620-006-9224-z","article-title":"Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis","volume":"52","author":"Winkler","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.bpg.2014.04.001_bib71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/gut.2005.074971","article-title":"Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease","volume":"55","author":"Lindsay","year":"2006","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bpg.2014.04.001_bib72","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1136\/gut.2010.232025","article-title":"Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease","volume":"60","author":"Benjamin","year":"2011","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bpg.2014.04.001_bib73","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1365-2036.2010.04417.x","article-title":"Clinical trial: the microbiological and immunological effects of synbiotic consumption - a randomized double-blind placebo-controlled study in active Crohn's disease","volume":"32","author":"Steed","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.bpg.2014.04.001_bib74","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1440-1746.2006.04535.x","article-title":"High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease","volume":"22","author":"Fujimori","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.bpg.2014.04.001_bib75","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10620-006-9549-7","article-title":"Failure of synbiotic 2000 to prevent postoperative recurrence of Crohn's disease","volume":"52","author":"Chermesh","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.bpg.2014.04.001_bib76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.crohns.2009.12.002","article-title":"The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management","volume":"4","author":"Dignass","year":"2010","journal-title":"J\u00a0Crohns Colitis"},{"issue":"8","key":"10.1016\/j.bpg.2014.04.001_bib77","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2036.2006.02879.x","article-title":"Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin","volume":"23","author":"Prantera","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.bpg.2014.04.001_bib78","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2007.03.031","article-title":"Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease","volume":"132","author":"Selby","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2014.04.001_bib79","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib80","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1586\/egh.11.71","article-title":"Fecal microbiota transplantation: current status and future directions","volume":"5","author":"Borody","year":"2011","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.bpg.2014.04.001_bib81","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2036.2012.05220.x","article-title":"Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease","volume":"36","author":"Anderson","year":"2012","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691814000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T19:43:40Z","timestamp":1597779820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691814000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1521691814000456"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2014.04.001","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring & exploiting our \u2018other self\u2019 \u2013 Does the microbiota hold the key to the future therapy in Crohn's?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2014.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}